ADMA Biologics Quarterly Income Statements Chart
Quarterly
|
Annual
ADMA Biologics Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenues | 121,984,000 | 114,802,000 | 117,549,000 | 119,839,000 | 107,191,000 | 81,875,000 | 73,903,677 | 67,274,598 | 60,123,191 | 56,913,534 | 792,935 | 523,284 | 360,338 | 230,096 | 4,400 | |||||||||||||||||||||||||||||||||||||||
| yoy | 13.80% | 40.22% | 59.06% | 78.13% | 78.29% | 43.86% | 17921.25% | |||||||||||||||||||||||||||||||||||||||||||||||
| qoq | 6.26% | -2.34% | -1.91% | 11.80% | 30.92% | 10.79% | 9.85% | 11.89% | 5.64% | 51.53% | 45.22% | 56.60% | 5129.45% | |||||||||||||||||||||||||||||||||||||||||
| cost of product revenue | 54,757,000 | 53,705,000 | 54,216,000 | 60,180,000 | 49,738,000 | 42,767,000 | 42,817,255 | 42,622,013 | 43,433,188 | 40,400,544 | 35,804,379 | 31,433,496 | 26,135,614 | 25,441,046 | 22,871,382 | 20,295,213 | 18,832,624 | 17,770,122 | 19,111,107 | 11,855,464 | 13,495,629 | 16,829,226 | 11,691,603 | 7,916,220 | 10,491,236 | 9,405,179 | 11,142,116 | 9,164,109 | 9,645,662 | 12,242,748 | 11,922,899 | 11,291,116 | 4,334,019 | 1,616,287 | 2,014,328 | 1,735,771 | 1,344,241 | 1,266,421 | 1,502,735 | 1,112,782 | 786,315 | 909,629 | 956,841 | 867,681 | 940,815 | 977,030 | 282,389 | 726,245 | 485,761 | |||||
| gross profit | 67,227,000 | 61,097,000 | 63,333,000 | 59,659,000 | 57,453,000 | 39,108,000 | 31,086,422 | 24,652,585 | 16,690,003 | 16,512,990 | 14,177,076 | 9,656,641 | 7,769,393 | 3,662,047 | 263,889 | 142,989 | 215,647 | 88,226 | ||||||||||||||||||||||||||||||||||||
| yoy | 17.01% | 56.23% | 103.73% | 142.00% | 244.24% | 136.83% | 119.27% | 155.29% | 114.82% | 350.92% | ||||||||||||||||||||||||||||||||||||||||||||
| qoq | 10.03% | -3.53% | 6.16% | 3.84% | 46.91% | 25.80% | 26.10% | 47.71% | 1.07% | 16.48% | 46.81% | 24.29% | 112.16% | 84.55% | -33.69% | 144.43% | ||||||||||||||||||||||||||||||||||||||
| gross margin % | 55.11% | 53.22% | 53.88% | 49.78% | 53.60% | 47.77% | 42.06% | 36.64% | 27.76% | 29.01% | 33.28% | 27.33% | 59.85% | 38.34% | 0% | |||||||||||||||||||||||||||||||||||||||
| operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| research and development | 1,031,000 | 826,000 | 391,000 | 412,000 | 560,000 | 450,000 | 445,486 | 595,903 | 1,403,260 | 855,351 | 1,074,320 | 1,041,947 | 873,386 | 624,111 | 728,988 | 770,557 | 1,158,866 | 987,649 | 1,013,464 | 1,708,391 | 1,656,420 | 1,528,738 | 464,823 | 491,404 | 516,986 | 870,635 | -144,920 | 1,317,234 | 1,472,100 | 1,281,706 | 1,864,382 | 1,814,069 | 1,358,409 | 1,192,727 | 583,374 | 1,677,263 | 3,399,889 | 2,027,712 | 1,996,808 | 2,111,505 | 1,505,909 | 1,401,723 | 1,919,719 | 1,482,929 | 1,783,909 | 4,330,457 | 2,956,153 | 1,408,990 | 3,470,350 | 1,467,584 | ||||
| plasma center operating expenses | 1,152,000 | 1,286,000 | 1,277,000 | 1,021,000 | 942,000 | 1,005,000 | 685,215 | 466,898 | 1,333,424 | 1,780,463 | 5,087,571 | 4,859,450 | 3,921,486 | 3,974,589 | 4,096,833 | 3,146,221 | 2,803,326 | 2,242,343 | 1,572,607 | 1,218,898 | 877,902 | 500,644 | 464,131 | 456,899 | 594,113 | 654,486 | 2,260,379 | 1,973,338 | 1,738,128 | 419,103 | 489,300 | 379,168 | 461,493 | |||||||||||||||||||||
| amortization of intangible assets | 32,000 | 25,000 | 25,000 | 28,000 | 142,000 | 193,000 | 187,486 | 178,838 | 178,838 | 178,838 | 178,839 | 178,838 | 178,838 | 178,838 | 178,839 | 178,838 | 178,838 | 178,838 | 178,839 | 178,838 | 178,838 | 178,838 | 211,234 | 211,235 | 211,234 | 211,235 | ||||||||||||||||||||||||||||
| selling, general and administrative | 22,214,000 | 24,079,000 | 23,317,000 | 18,560,000 | 16,608,000 | 15,639,000 | 15,534,999 | 14,725,787 | 14,247,558 | 14,511,656 | 13,894,888 | 12,893,139 | 11,970,422 | 13,699,575 | 11,698,009 | 10,726,797 | 10,438,168 | 10,033,915 | 9,300,359 | 9,115,744 | 8,702,630 | 7,932,084 | 7,032,067 | 7,197,173 | 6,086,047 | 5,595,470 | 7,135,275 | 5,355,794 | 5,006,807 | 5,005,046 | 5,184,337 | 4,195,464 | 4,435,650 | |||||||||||||||||||||
| total operating expenses | 24,429,000 | 26,216,000 | 25,010,000 | 20,021,000 | 18,252,000 | 17,287,000 | 16,853,186 | 15,967,426 | 17,163,080 | 17,326,308 | 20,235,618 | 18,973,374 | 16,944,132 | 18,477,113 | -40,195,290 | 35,117,626 | 33,411,822 | 31,212,867 | 31,176,376 | 24,077,335 | 24,911,419 | 26,969,530 | 19,863,858 | 16,272,931 | 17,899,616 | 16,737,005 | 20,604,084 | 18,021,710 | 18,073,931 | 20,574,509 | 22,546,242 | 19,157,171 | 11,801,269 | 8,565,874 | 7,271,681 | 6,674,735 | 7,762,594 | 6,282,422 | 6,642,848 | 6,516,611 | 4,826,538 | 4,705,443 | 5,197,682 | 4,404,212 | 5,087,639 | 7,244,545 | 4,942,275 | 3,638,312 | 5,586,397 | 3,413,978 | 2,383,296 | 3,464,467 | 1,294,766 | |
| income from operations | 42,798,000 | 34,881,000 | 38,323,000 | 39,638,000 | 39,201,000 | 21,821,000 | 14,233,236 | 8,685,159 | -473,077 | -813,318 | -6,058,542 | -9,316,733 | -9,174,739 | -14,815,066 | -13,191,184 | -14,437,076 | -15,581,232 | -15,164,249 | -17,220,289 | -13,800,977 | -17,123,825 | -16,769,786 | -7,826,809 | -9,050,428 | -11,338,674 | -13,208,416 | -16,547,660 | -13,791,400 | -13,417,381 | -16,532,503 | -10,543,365 | -14,427,760 | -8,401,868 | -5,937,003 | -3,944,137 | -3,736,872 | -5,490,850 | -4,158,536 | -4,130,667 | -4,664,198 | -3,516,605 | -3,202,337 | -3,708,945 | -3,038,282 | -3,587,320 | -5,683,986 | -4,518,244 | -2,530,971 | -4,843,127 | -3,150,089 | -2,240,307 | -3,248,820 | -1,206,540 | -1,213,502 |
| yoy | 9.18% | 59.85% | 169.25% | 356.39% | -8386.39% | -2782.96% | -334.93% | -193.22% | -94.84% | -94.51% | -54.07% | -35.47% | -41.12% | -2.30% | -23.40% | 4.61% | -9.01% | -9.57% | 120.02% | 52.49% | 51.02% | 26.96% | -52.70% | -34.38% | -15.49% | -20.11% | 56.95% | -4.41% | 59.70% | 178.47% | 167.32% | 286.09% | 53.02% | 42.77% | -4.52% | -19.88% | 56.14% | 29.86% | 11.37% | 53.51% | -1.97% | -43.66% | -17.91% | 20.04% | -25.93% | 80.44% | 101.68% | -22.10% | 301.41% | 159.59% | ||||
| qoq | 22.70% | -8.98% | -3.32% | 1.11% | 79.65% | 53.31% | 63.88% | -1935.89% | -41.83% | -86.58% | -34.97% | 1.55% | -38.07% | 12.31% | -8.63% | -7.34% | 2.75% | -11.94% | 24.78% | -19.40% | 2.11% | 114.26% | -13.52% | -20.18% | -14.16% | -20.18% | 19.99% | 2.79% | -18.84% | 56.80% | -26.92% | 71.72% | 41.52% | 50.53% | 5.55% | -31.94% | 32.04% | 0.67% | -11.44% | 32.63% | 9.81% | -13.66% | 22.07% | -15.30% | -36.89% | 25.80% | 78.52% | -47.74% | 53.75% | 40.61% | -31.04% | 169.27% | -0.57% | |
| operating margin % | 35.08% | 30.38% | 32.60% | 33.08% | 36.57% | 26.65% | 19.26% | 12.91% | -0.79% | -1.43% | -397.27% | -428.12% | -901.60% | -524.36% | -27579.59% | |||||||||||||||||||||||||||||||||||||||
| other income: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| interest income | 400,000 | 608,000 | 598,000 | 666,000 | 449,000 | 384,000 | 612,449 | 423,276 | 414,304 | 166,971 | 2,260 | 7,236 | 2,269 | 33,068 | 2,291 | 4,256 | 5,926 | 22,059 | 60,206 | 75,581 | 33,070 | 26,546 | 8,610 | 8,014 | 7,858 | 18,568 | 13,187 | 11,605 | 12,017 | 13,508 | 11,952 | 11,102 | 9,795 | 4,982 | 5,305 | 3,508 | 3,625 | 1,779 | 1,965 | 2,145 | 3,003 | 510 | 2,923 | 7,067 | ||||||||||
| interest expense | -2,879,000 | -3,499,000 | -3,783,000 | -3,769,000 | -6,214,856 | -6,397,553 | -6,299,107 | -6,115,484 | -5,736,954 | -5,580,366 | -4,573,015 | -3,389,038 | -3,315,724 | -3,298,680 | -3,246,680 | -3,195,750 | -3,109,469 | -3,091,200 | -3,067,306 | -2,717,091 | -2,730,890 | -2,649,404 | -2,072,578 | -1,540,507 | -1,437,968 | -1,402,475 | -1,359,188 | -1,323,152 | -1,241,865 | -782,969 | -642,485 | -618,528 | -628,158 | -605,972 | -537,998 | -467,441 | -463,938 | -449,328 | -453,411 | -476,040 | -381,281 | -335,299 | -342,750 | -226,885 | -167,651 | -162,934 | -158,844 | -128,796 | -3,098 | -8,494 | ||||
| loss on extinguishment of debt | -6,669,941 | -9,962,495 | -719,097 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| other income | -86,000 | -56,000 | -16,000 | -35,000 | -101,362 | -145,827 | -12,827 | -26,984 | -438,447 | -9,641 | -19,421 | -166,880 | -144,803 | 18,546 | -83,317 | -42,001 | -89,296 | -26,440 | -6,371 | -6,421 | -185,014 | -20,523 | -10,428 | -11,357 | -112,565 | -17,191 | -4,332 | 6,967 | -594,367 | 4,496 | -453,933 | -451,986 | -438,226 | -235,054.5 | -346,407 | 82,497 | 367.75 | 3,073 | ||||||||||||||||
| income before income taxes | 40,097,000 | 33,450,000 | 34,713,000 | 36,749,000 | 35,851,000 | 18,401,000 | -4,701,208 | -2,688,947 | -4,895,444 | -3,241,647 | -2,251,537 | -3,245,747 | -1,206,715 | -1,214,929 | ||||||||||||||||||||||||||||||||||||||||
| benefit from income taxes | 5,878,000 | 6,546,000 | 1,306,000 | 840,000 | 3,789,000 | 595,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| net income | 34,219,000 | 26,904,000 | 111,896,000 | 35,909,000 | 32,062,000 | 17,806,000 | -17,644,533 | 2,565,055 | -6,370,707 | -6,788,815 | -12,231,683 | -14,899,504 | -13,764,906 | -25,007,857 | -16,649,420 | -17,712,954 | -18,905,303 | -18,379,941 | -19,407,774 | -16,917,453 | -20,178,091 | -19,245,230 | -10,561,031 | -11,438,459 | -13,211,872 | -13,067,955 | -18,037,987 | -15,135,485 | -14,747,831 | -17,822,142 | -12,982,802 | -15,202,715 | -9,036,495 | -6,536,963 | -4,559,108 | -4,331,239 | -6,012,335 | -4,612,469 | -4,582,653 | -5,102,424 | -4,679,318 | -3,605,535 | -3,563,357 | -3,384,689 | -3,961,245 | -5,903,872 | -4,701,208 | -2,688,947 | -4,895,444 | -3,241,647 | -2,251,537 | -3,245,747 | -1,206,715 | -597,314 |
| yoy | 6.73% | 51.10% | -734.17% | 1299.93% | -603.27% | -362.28% | 44.25% | -117.22% | -53.72% | -72.85% | -26.53% | -15.88% | -27.19% | 36.06% | -14.21% | 4.70% | -6.31% | -4.50% | 83.77% | 47.90% | 52.73% | 47.27% | -41.45% | -24.43% | -10.41% | -26.68% | 38.94% | -0.44% | 63.20% | 172.64% | 184.77% | 251.00% | 50.30% | 41.72% | -0.51% | -15.11% | 28.49% | 27.93% | 28.60% | 50.75% | 18.13% | -38.93% | -24.20% | 25.87% | -19.08% | 82.13% | 108.80% | -17.15% | 305.68% | 442.70% | ||||
| qoq | 27.19% | -75.96% | 211.61% | 12.00% | 80.06% | -200.92% | -787.88% | -140.26% | -6.16% | -44.50% | -17.91% | 8.24% | -44.96% | 50.20% | -6.00% | -6.31% | 2.86% | -5.30% | 14.72% | -16.16% | 4.85% | 82.23% | -7.67% | -13.42% | 1.10% | -27.55% | 19.18% | 2.63% | -17.25% | 37.28% | -14.60% | 68.24% | 38.24% | 43.38% | 5.26% | -27.96% | 30.35% | 0.65% | -10.19% | 9.04% | 29.78% | 1.18% | 5.28% | -14.55% | -32.90% | 25.58% | 74.83% | -45.07% | 51.02% | 43.97% | -30.63% | 168.97% | 102.02% | |
| net income margin % | 28.05% | 23.44% | 95.19% | 29.96% | 29.91% | 21.75% | -23.88% | 3.81% | -10.60% | -11.93% | -408.82% | -430.27% | -900.75% | -524.44% | -13575.32% | |||||||||||||||||||||||||||||||||||||||
| basic earnings per common share | 140 | 110 | 480 | 150 | 140 | 80 | ||||||||||||||||||||||||||||||||||||||||||||||||
| diluted earnings per common share | 140 | 110 | 460 | 150 | 130 | 80 | ||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average common shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 241,490,715,000 | 237,775,476,000 | 233,084,236,000 | 234,571,376,000 | 232,417,645,000 | 228,874,847,000 | 225,276,980 | |||||||||||||||||||||||||||||||||||||||||||||||
| diluted | 248,608,460,000 | 244,676,350,000 | 243,342,466,000 | 244,804,065,000 | 242,167,072,000 | 236,414,374,000 | 233,761,262 | |||||||||||||||||||||||||||||||||||||||||||||||
| basic income per common share | -0.013 | 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted income per common share | -0.013 | 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic and diluted loss per common share | -0.03 | -0.03 | -0.06 | -0.08 | -0.07 | -0.13 | -0.07 | -0.13 | -0.15 | -0.16 | -0.2 | -0.19 | -0.23 | -0.26 | -0.17 | -0.19 | -0.25 | -0.28 | -0.39 | -0.33 | -0.35 | -0.39 | -0.24 | -0.59 | -0.55 | |||||||||||||||||||||||||||||
| weighted-average common shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic and diluted | 223,977,315,000 | 222,683,393 | 221,921,750 | 197,874,895 | 196,383,935 | 196,353,185 | 195,871,932 | 139,578,538 | 133,770,147 | 127,416,126 | 115,661,937 | 86,145,052 | 87,698,258 | 86,347,467 | 73,781,507 | 54,348,136 | 59,317,830 | 52,206,204 | 46,353,068 | 45,188,899 | 46,350,392 | 42,712,168 | 45,317,042 | 22,896,042 | 25,790,805 | 16,427,054 | ||||||||||||||||||||||||||||
| revenues: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| product revenue | 49,945,746 | 41,054,429 | 33,869,298 | 29,067,385 | 26,347,158 | 20,644,842 | 17,794,881 | 16,012,910 | 13,920,378 | 10,240,650 | 7,751,885 | 10,164,036 | 12,001,340 | 7,186,795 | 6,525,233 | 3,492,881 | 4,020,715 | 4,194,602 | 4,620,841 | 4,006,298 | 4,967,168 | 4,693,703 | 3,363,692 | 2,593,163 | 3,291,835 | 2,902,155 | 2,236,035 | 2,088,178 | 2,453,793 | 1,821,229 | 1,291,044 | 1,484,217 | 1,469,848 | 1,347,041 | 1,481,430 | 1,541,670 | 405,142 | 1,088,452 | 736,974 | |||||||||||||||
| license revenue | 35,709 | 35,708 | 35,709 | 35,708 | 35,709 | 35,708 | 35,709 | 35,708 | 35,709 | 35,708 | 35,709 | 35,708 | 35,709 | 35,708 | 35,709 | 35,708 | 17,240.5 | 31,184 | 18,889 | 18,889 | 18,889 | 18,889 | 18,889 | 18,889 | 18,889 | 18,889 | 6,296 | |||||||||||||||||||||||||||
| total revenues | 49,981,455 | 41,090,137 | 33,905,007 | 29,103,093 | 26,382,867 | 20,680,550 | 17,830,590 | 16,048,618 | 13,956,087 | 10,276,358 | 7,787,594 | 10,199,744 | 12,037,049 | 7,222,503 | 6,560,942 | 3,528,589 | 4,056,424 | 4,230,310 | 4,656,550 | 4,042,006 | 12,002,877 | 4,729,411 | 3,399,401 | 2,628,871 | 3,327,544 | 2,937,863 | 2,271,744 | 2,123,886 | 2,512,181 | 1,852,413 | 1,309,933 | 1,503,106 | 1,488,737 | 1,365,930 | 1,500,319 | 1,560,559 | 424,031 | 1,107,341 | 743,270 | |||||||||||||||
| interest and other income | 67,160.75 | 1,164 | 19,411 | 248,068 | 154,775.75 | 281,896 | 209,808 | 127,399 | ||||||||||||||||||||||||||||||||||||||||||||||
| gain on transfer of plasma center assets | 11,527,421 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| license and other revenue | 26,781.25 | 35,708 | 35,709 | 35,708 | 26,781.25 | 35,708 | 35,709 | 35,708 | 35,709 | 35,708 | 35,709 | 35,708 | ||||||||||||||||||||||||||||||||||||||||||
| amortization of intangibles | 158,426 | 211,235 | 211,234 | 211,235 | 887,825 | 273,828 | 73,021 | |||||||||||||||||||||||||||||||||||||||||||||||
| plasma centers | 1,833,774 | 1,841,410 | 1,582,694 | 1,600,170 | 1,479,476 | 1,390,385 | 1,482,586 | 1,294,301 | 1,280,419 | 1,258,935 | 1,214,158 | 1,096,878 | 660,425 | 1,018,382 | 820,849 | |||||||||||||||||||||||||||||||||||||||
| general and administrative | 4,277,384 | 3,283,594 | 1,779,115 | 1,724,163 | 1,707,870 | 1,884,370 | 2,078,166 | 1,437,436 | 1,345,997 | 1,111,994 | 1,035,220 | 1,542,066 | 1,134,589 | 998,635 | 845,301 | |||||||||||||||||||||||||||||||||||||||
| other income,net | -599,960 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income per common share, | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic and diluted | -0.51 | -0.35 | -0.34 | -0.5 | -0.43 | -0.45 | -0.48 | -0.44 | -0.37 | -0.358 | -0.36 | -0.43 | -0.64 | -0.46 | -0.46 | -0.83 | ||||||||||||||||||||||||||||||||||||||
| weighted-average shares | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| outstanding, basic and diluted | 12,886,741 | 247,131 | 12,886,741 | 12,121,500 | 10,710,587 | -13,005 | 10,707,728 | 9,855,323 | 2,322,955.75 | 9,291,823 | 9,291,823 | 9,291,823 | 1,467,750.5 | 5,871,002 | 5,871,002 | |||||||||||||||||||||||||||||||||||||||
| change in fair value of stock warrants | 67,860 | -30,160 | -14,616 | -34,800 | 5,220 | -17,278 | 2,813 | 21,027 | 36,728 | |||||||||||||||||||||||||||||||||||||||||||||
| total other income | -1,162,713 | -403,198 | -373,925 | -219,886 | -75,462.75 | -157,976 | -52,317 | -91,558 | -175 | -1,427 | ||||||||||||||||||||||||||||||||||||||||||||
| weighted-averageshares | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| outstanding, basic anddiluted | 10,705,573 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| plasma center | 1,048,094 | 802,469 | 705,098 | 657,776 | 539,994 | 515,288 | ||||||||||||||||||||||||||||||||||||||||||||||||
| net income per common share | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic and diluted | -0.51 | -0.35 | -0.34 | -0.5 | -0.43 | -0.45 | -0.48 | -0.44 | -0.37 | -0.358 | -0.36 | -0.43 | -0.64 | -0.46 | -0.46 | -0.83 | ||||||||||||||||||||||||||||||||||||||
| state income tax benefit | 617,615 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| general and adminstrative | 1,090,292 | 1,431,106 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| cost of sales | 529,046 | 72,190.25 | 144,691 | 141,870 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| net income per common share, basic and diluted | -0.55 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average number of | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| common shares outstanding, basic and diluted | 5,871,002 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| operating expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| research and development expenses | 1,267,947 | 1,940,637 | 178,674 | 81,820 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| loss on sale of research and development inventory | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| general and administrative expenses | 696,246 | 1,034,530 | 736,924 | 674,589 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| net income per share | -0.49 | -0.7 | -0.26 | -0.23 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average shares outstanding – basic and diluted | 4,654,303 | 4,654,303 | 2,648,087 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| costs and expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total costs and expenses | 1,217,902 |
We provide you with 20 years income statements for ADMA Biologics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ADMA Biologics stock. Explore the full financial landscape of ADMA Biologics stock with our expertly curated income statements.
The information provided in this report about ADMA Biologics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.